BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25064451)

  • 1. Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer.
    Kiesslich T; Mayr C; Wachter J; Bach D; Fuereder J; Wagner A; Alinger B; Pichler M; Di Fazio P; Ocker M; Berr F; Neureiter D
    Mol Cell Biochem; 2014 Nov; 396(1-2):257-68. PubMed ID: 25064451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer.
    Zuo M; Rashid A; Churi C; Vauthey JN; Chang P; Li Y; Hung MC; Li D; Javle M
    Br J Cancer; 2015 Mar; 112(6):1042-51. PubMed ID: 25742482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of
    Kohara Y; Haraguchi R; Kitazawa R; Imai Y; Kitazawa S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
    Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
    Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sonic hedgehog pathway as a treatment target for extrahepatic biliary tract cancer.
    Kim YJ; Park SB; Park JY; Park SW; Chung JB; Song SY; Bang S
    Mol Med Rep; 2012 Jan; 5(1):12-6. PubMed ID: 21946948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
    Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
    Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
    Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
    Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inhibition of hedgehog signaling on cell growth and migration of uveal melanoma cells.
    Duan F; Lin M; Li C; Ding X; Qian G; Zhang H; Ge S; Fan X; Li J
    Cancer Biol Ther; 2014 May; 15(5):544-59. PubMed ID: 24553082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer.
    Mazumdar T; DeVecchio J; Agyeman A; Shi T; Houghton JA
    Oncotarget; 2011 Aug; 2(8):638-45. PubMed ID: 21860067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedgehog pathway signaling regulates human colon carcinoma HT-29 epithelial cell line apoptosis and cytokine secretion.
    Yoshimoto AN; Bernardazzi C; Carneiro AJ; Elia CC; Martinusso CA; Ventura GM; Castelo-Branco MT; de Souza HS
    PLoS One; 2012; 7(9):e45332. PubMed ID: 23028941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer.
    Zhang H; Hu L; Cheng M; Wang Q; Hu X; Chen Q
    Oncol Rep; 2020 Dec; 44(6):2610-2620. PubMed ID: 33125122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-proliferation of breast cancer cells with itraconazole: Hedgehog pathway inhibition induces apoptosis and autophagic cell death.
    Wang X; Wei S; Zhao Y; Shi C; Liu P; Zhang C; Lei Y; Zhang B; Bai B; Huang Y; Zhang H
    Cancer Lett; 2017 Jan; 385():128-136. PubMed ID: 27810405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft.
    Fu J; Rodova M; Roy SK; Sharma J; Singh KP; Srivastava RK; Shankar S
    Cancer Lett; 2013 Mar; 330(1):22-32. PubMed ID: 23200667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.
    McCann CK; Growdon WB; Kulkarni-Datar K; Curley MD; Friel AM; Proctor JL; Sheikh H; Deyneko I; Ferguson JA; Vathipadiekal V; Birrer MJ; Borger DR; Mohapatra G; Zukerberg LR; Foster R; Macdougall JR; Rueda BR
    PLoS One; 2011; 6(11):e28077. PubMed ID: 22140510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.
    Bongiovanni D; Tosello V; Saccomani V; Dalla Santa S; Amadori A; Zanovello P; Piovan E
    Oncogene; 2020 Oct; 39(42):6544-6555. PubMed ID: 32917954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog signaling drives cellular survival in human colon carcinoma cells.
    Mazumdar T; DeVecchio J; Shi T; Jones J; Agyeman A; Houghton JA
    Cancer Res; 2011 Feb; 71(3):1092-102. PubMed ID: 21135115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism.
    Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG
    Cancer Lett; 2019 Feb; 442():341-350. PubMed ID: 30447254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma.
    Pietrobono S; Gaudio E; Gagliardi S; Zitani M; Carrassa L; Migliorini F; Petricci E; Manetti F; Makukhin N; Bond AG; Paradise BD; Ciulli A; Fernandez-Zapico ME; Bertoni F; Stecca B
    Oncogene; 2021 Jun; 40(22):3799-3814. PubMed ID: 33958721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
    Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P
    Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.